EVRAZ plc
LSE:EVR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
EVRAZ plc
LSE:EVR
|
UK |
|
I
|
Indutrade AB
LSE:0H30
|
SE |
|
Sellas Life Sciences Group Inc
NASDAQ:SLS
|
US |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
A
|
Astera Labs Inc
NASDAQ:ALAB
|
US |
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
US |
|
Abacus Global Management Inc
NYSE:ABX
|
US |
|
Deutsche Lufthansa AG
LSE:0H4A
|
DE |
|
Berry Global Group Inc
NYSE:BERY
|
US |
|
G
|
Geely Automobile Holdings Ltd
DUS:GRU
|
HK |
|
N
|
Nirlon Ltd
BSE:500307
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVR's stock price target?
Not Available
EVR does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for EVRAZ plc?
Projected CAGR
-13%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 1 year is -13%.
What is the Net Income forecast for EVRAZ plc?
Projected CAGR
-59%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 1 year is -59%.